Pharma 64: Antiretroviral Therapy - Holding the Line Without Cure

This episode explores HIV pharmacology as the discipline of durable containment. HIV integrates into host DNA, mutates rapidly, and rebounds when pressure slips-making cure elusive but control achievable. We trace the viral life cycle to understand why combination therapy is essential, how high genetic barriers protect efficacy, and why adherence is the cornerstone of success. The episode frames modern ART not as a single drug story, but as a systems achievement where timing, combinations, and lifelong partnership matter.Key takeaways to secure mastery:* Lifecycle targeting: entry, reverse transcription, integration, protease processing.* Combination logic: why multi-class regimens prevent resistance.* Genetic barriers: what makes some regimens more forgiving than others.* Adherence reality: missed doses as the true enemy of control.* Public health lens: viral suppression as prevention (U=U). This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe